Moderna Inc

FDA authorizes Novavax’s Covid shots as mix-and-match booster to Pfizer or Moderna
The Food and Drug Administration has authorized Novavax‘s Covid boosters for adults in the U.S., including for people who received Pfizer’s or Moderna’s shots as their primary series. The authorization of Novavax’s booster could significantly increase the role that its shot plays in U.S. vaccination efforts. Up until now, Novavax’s vaccine was only authorized as […]
Read More
This week’s most effective-executing stocks contain two pharma names analysts hope will rally from below
Some of the major inventory winners in this week’s volatile industry action integrated two huge pharmaceutical names analysts expect to rally in the months in advance. Shares staged a historic rally on Thursday, with the S & P 500 submitting just one of its largest-ever intraday reversals from a very low, as buyers weighed fresh […]
Read More
Stocks making the biggest moves midday: Moderna, Pepsi, Lyft and more
In this article CCO-CA AAL RKLB KNBE LOCO PHIA-NL LYFT PEP AIG TROW MRNA Follow your favorite stocksCREATE FREE ACCOUNT Pepsi products are displayed for sale in a Target store on March 8, 2022 in Los Angeles, California. Mario Tama | Getty Images Check out the companies making the biggest moves midday Wednesday: Moderna — […]
Read More
FDA authorizes Covid omicron booster shots for kids as young as 5 years old
The Food and Drug Administration on Wednesday authorized Covid booster shots that target the omicron variant for preschoolers through elementary school students. Pfizer’s new omicron boosters are authorized for children ages 5 to 11 and Moderna’s shots for kids ages 6 through 17. The shots are administered two months following completion of the two-dose primary […]
Read More
Moderna and Merck will jointly develop a cancer vaccine for high-risk melanoma patients
Pipettes are seen at the Moderna Therapeutics Inc. lab in Cambridge, Massachusetts, U.S., on Tuesday, Nov. 14, 2017. Moderna this week started testing Adam Glanzman | Bloomberg | Getty Images Moderna and Merck will jointly develop and sell a cancer vaccine that is personalized for individual patients, the companies announced on Wednesday. Moderna’s vaccine, based […]
Read More
A series of mega-blockbuster drugs are on the horizon. How to invest in the trend
Biopharma companies are having more clinical success treating Alzheimer’s disease and obesity and are taking new approaches in oncology, and that’s creating more mega-blockbuster drugs, according to Bank of America. Analyst Geoff Meacham has identified 20 drugs that have the potential to generate $10 billion or more in annual sales by 2030 within the universe […]
Read More
Goldman analysts predict these stocks have the most to gain, including 4 that will double
As Wall Street rebounds to start a new quarter, Goldman Sachs analysts searched for stocks that have the most to gain from here. The Dow Jones Industrial Average kicked off October with its best day since June after jumping more than 700 points on Monday. The S & P 500 advanced about 2.6%, while the […]
Read More
Covid vaccination linked to slight increase in menstrual cycle, NIH study confirms
A healthcare worker administers a dose of the Pfizer-BioNTech Covid-19 vaccine at a vaccination clinic in the Peabody Institute Library in Peabody, Massachusetts, U.S., on Wednesday, Jan. 26, 2022. Vanessa Leroy | Bloomberg | Getty Images Covid-19 vaccination is linked to a slight increase in the length of a women’s menstrual cycle, delaying the beginning […]
Read More
Stocks generating the biggest moves midday: Hertz, Ford, Keurig Dr Pepper and far more
In this posting HTZ KDP LCID VLO NCLH RCL Follow your most loved sharesMake Cost-free ACCOUNT Andrew Kelly | Reuters Check out out the firms making the most significant moves midday: Hertz — Shares of the rental auto enterprise jumped 1.9% soon after the business declared a partnership with BP’s electric powered vehicle charging device […]
Read More